Your browser doesn't support javascript.
loading
BMSC derived EVs inhibit colorectal Cancer progression by transporting MAGI2-AS3 or something similar.
Ma, Tianyi; Wang, Meng; Wang, Song; Hu, Hanqing; Zhang, Xin; Wang, Hufei; Wang, Guiyu; Jin, Yinghu.
Afiliación
  • Ma T; Department of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin 150000, China.
  • Wang M; Department of Colorectal Surgery, Zhejiang Cancer Hospital (Affiliated Cancer Hospital of the Chinese Academy of Sciences), Hangzhou 310000, China.
  • Wang S; Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China.
  • Hu H; Department of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin 150000, China.
  • Zhang X; Department of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin 150000, China.
  • Wang H; Department of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin 150000, China.
  • Wang G; Department of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin 150000, China. Electronic address: guiywang@163.com.
  • Jin Y; Department of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin 150000, China. Electronic address: 33887443@qq.com.
Cell Signal ; 121: 111235, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38806109
ABSTRACT
In this study, we investigated the molecular mechanisms underlying the impact of extracellular vesicles (EVs) derived from bone marrow stromal cells (BMSCs) on colorectal cancer (CRC) development. The focus was on the role of MAGI2-AS3, delivered by BMSC-EVs, in regulating USP6NL DNA methylation-mediated MYC protein translation modification to promote CDK2 downregulation. Utilizing bioinformatics analysis, we identified significant enrichment of MAGI2-AS3 related to copper-induced cell death in CRC. In vitro experiments demonstrated the downregulation of MAGI2-AS3 in CRC cells, and BMSC-EVs were found to deliver MAGI2-AS3 to inhibit CRC cell proliferation, migration, and invasion. Further exploration revealed that MAGI2-AS3 suppressed MYC protein translation modification by regulating USP6NL DNA methylation, leading to CDK2 downregulation and prevention of colorectal cancer. Overexpression of MYC reversed the functional effects of BMSC-EVs-MAGI2-AS3. In vivo experiments validated the inhibitory impact of BMSC-EVs-MAGI2-AS3 on CRC tumorigenicity by promoting CDK2 downregulation through USP6NL DNA methylation-mediated MYC protein translation modification. Overall, BMSC-EVs-MAGI2-AS3 may serve as a potential intervention to prevent CRC occurrence by modulating key molecular pathways.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Vesículas Extracelulares Límite: Animals / Humans Idioma: En Revista: Cell Signal Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Vesículas Extracelulares Límite: Animals / Humans Idioma: En Revista: Cell Signal Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido